ReviewJournal of labelled compounds & radiopharmaceuticals2018
Hypervalent aryliodine compounds as precursors for radiofluorination.
Review in Journal of labelled compounds & radiopharmaceuticals, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Triarylselenonium triflates provide efficient access to no-carrier-addedChemical science · 2026Article
- Iodoarene Activation: Take a Leap Forward toward Green and Sustainable Transformations.Chemical reviews · 2025Review
- Simple and Efficient Synthesis ofPharmaceuticals (Basel, Switzerland) · 2024Article
- Recent Progress in Synthetic Applications of Hypervalent Iodine(III) Reagents.Chemical reviews · 2024Review
- Astatine-211 radiolabelling chemistry: from basics to advanced biological applications.EJNMMI radiopharmacy and chemistry · 2024Review
- Difluoromethoxide Is a Strong Leaving Group in the Photoredox Deoxyradiofluorination of 2-Phenylpyridines.The Journal of organic chemistry · 2024Article
- Isotopologues of potassium 2,2,2-trifluoroethoxide for applications in positron emission tomography and beyond.Nature communications · 2024Article
- On the Risk ofOrganic letters · 2023Article
- Radiochemistry for positron emission tomography.Nature communications · 2023Review
- Broad-scope Syntheses of [Chemistry (Weinheim an der Bergstrasse, Germany) · 2023Article
- One-Pot Radiosynthesis of [Molecules (Basel, Switzerland) · 2023Article
- Oxidation-Cyclisation of Biphenyl Thioethers to Dibenzothiophenium Salts for UltrarapidInternational journal of molecular sciences · 2022Article
- Recent Advances inPharmaceutics · 2022Review
- Translating a radiolabeled imaging agent to the clinic.Advanced drug delivery reviews · 2022Review
- Synthesis and Screening in Mice of Fluorine-Containing PET Radioligands for TSPO: Discovery of a PromisingJournal of medicinal chemistry · 2021Article
- Automated synthesis ofEJNMMI radiopharmacy and chemistry · 2020Article
- Nucleophilic Synthesis of 6-l-[Molecules (Basel, Switzerland) · 2020Review
- Rapid Syntheses of [Organic letters · 2020Article
- Synthesis of high-molar-activity [Nature protocols · 2020Article
- [EJNMMI radiopharmacy and chemistry · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Over the last 2 decades or so, hypervalent iodine compounds, such as diaryliodonium salts and aryliodonium ylides, have emerged as useful precursors for labeling homoarenes and heteroarenes with no-carrier-added cyclotron-produced [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.